Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
about
Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes?Hyaluronan, Inflammation, and Breast Cancer ProgressionInteractions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerHyaluronan - a functional and structural sweet spot in the tissue microenvironmentThe adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activationAnti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritisBronchial epithelial injury in the context of alloimmunity promotes lymphocytic bronchiolitis through hyaluronan expression.Hyaluronan and hyaluronan-binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis.Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during Gram-negative pneumonia.A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.Extracellular matrix components in the pathogenesis of type 1 diabetes.Hyaluronan as an immune regulator in human diseases.Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity.MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis.Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation.Hyaluronic acid is radioprotective in the intestine through a TLR4 and COX-2-mediated mechanism.Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.Synthesis and characterization of a lubricin mimic (mLub) to reduce friction and adhesion on the articular cartilage surface.Hyaluronic acid regulates normal intestinal and colonic growth in mice.Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9.Hyaluronic acid-binding scaffold for articular cartilage repairExtracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronanBiomimetic molecules lower catabolic expression and prevent chondroitin sulfate degradation in an osteoarthritic ex vivo modelHyaluronan as a therapeutic target in human diseasesCD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmunToll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity.Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis.Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in miceActivated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid.Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice.Hyaluronic acid binding peptides prevent experimental staphylococcal wound infectionInterplay of extracellular matrix and leukocytes in lung inflammation.Modulation of the local neutrophil response by a novel hyaluronic acid-binding peptide reduces bacterial burden during staphylococcal wound infection.Development of a hyaluronan bioconjugate for the topical treatment of melanoma.Localized lentivirus delivery via peptide interactions.Inhibition of small HA fragment activity and stimulation of A2A adenosine receptor pathway limit apoptosis and reduce cartilage damage in experimental arthritis.Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury.CD44 and TLR4 mediate hyaluronic acid regulation of Lgr5+ stem cell proliferation, crypt fission, and intestinal growth in postnatal and adult mice.
P2860
Q26799151-C87199B0-885A-4F0E-B34C-BB9B55EB672EQ27006607-BBB1AB07-036D-4DBB-8E9A-75A668650B0DQ27021261-A1D63B10-B2BB-466C-A1BD-7B9713BF6749Q28081088-17D4B4B2-10E9-4CFE-9082-9712B6E9BD2CQ28360727-9712A7BA-5EDD-4BA6-97A9-AB285C142F09Q28363374-895289DB-1194-45BF-AAC4-99B420F4F803Q30579662-535EE685-A9CC-4647-AB46-A425FF4B31C6Q33959711-DBFB40A2-3D64-4CC7-97D6-520800E79EA5Q34003991-5CE2FD10-84F0-4ED6-A1A3-4F6662168080Q34254524-1EF34381-B194-4CEA-A4A0-99B9868CAC01Q34378734-774586CB-7559-4A6C-878D-405D9382FEEDQ34546894-D97019AF-B643-47B8-99C3-2EC1889B1232Q34636380-1C5213F0-BD5D-4DF7-8B32-4D0909C29216Q34978863-86B93BAE-1969-435E-979D-38BC17E996C1Q35185566-06CF86AA-BA50-4616-A00D-485F43C82A36Q35537464-CD9F3D52-F8B9-4E2D-BCDD-4A3E0905B04DQ35780923-C93BE310-CE2A-4D09-8E50-A682B2CB77F8Q36001335-CDE7DD60-6538-4F12-87A4-7C868F56244FQ36161950-0361CCDE-B44D-431D-AB32-13434F87C6DBQ36175941-C103EEF5-93D6-49F3-82A6-EC941F3B4681Q36324006-BF59D2C2-EDD6-4E72-BB7F-B1DDE02C1A14Q36408147-E1E837D3-0ABC-47E9-96D4-AC467E84D278Q36499699-D981BC49-EB77-4316-8F04-3ECEB690FEAFQ36567581-7E1C5077-BEB5-4B2C-937B-7BD28345DF4DQ36578627-D9271956-664C-4C32-804D-EB1BB3ADC9DBQ36831813-5F2EEC1B-1A14-4A1D-8854-050EB615A469Q36853445-3BF749C9-0A4F-49C8-B130-57BC5B92973AQ37127416-52DA7B6F-7ACD-463D-BCEF-CA2D39C1D7E7Q37241426-E3A9C6CC-78AE-4E06-B0F7-6D73400EDE2EQ37273173-7A6CF63C-B059-4CB5-827C-702A3A1A3598Q37463548-3B6BA736-D43A-4F42-AA25-25EC8A47589AQ38735180-D002112C-DAF9-4767-9814-870FA80623CFQ39077656-2D1A25A7-0CDC-4DD9-BB59-49207BAC0381Q39080263-88186D1B-1369-498A-9A6F-942F1DB5543AQ39678348-314AFA19-1468-42BE-9FEF-1C14C2616D6EQ39864058-A6ABE16A-AF7F-421C-8E74-A0963F493462Q40888779-AC3B0A3F-3743-4DFA-8C59-AA6D386D9FE0Q41685843-2F23BDBA-F032-40BB-9734-90A4B53800E5Q42066779-2C4AC0A1-199E-44F8-B880-BECFFE9B0675Q42181705-A1976CDB-9195-4B9B-BAE0-AB1620910A3F
P2860
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
@ast
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
@en
type
label
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
@ast
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
@en
prefLabel
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
@ast
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
@en
P2093
P2860
P356
P1476
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.
@en
P2093
A Takashima
D I Mummert
M E Mummert
M Mohamadzadeh
N Mizumoto
P2860
P304
P356
10.1084/JEM.192.6.769
P407
P577
2000-09-01T00:00:00Z